Clinical Trial Update: Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry

View source ↗

Summary

This clinical trial update summarizes the completion of a prospective observational registry assessing the use of eribulin for advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Halaven (eribulin)

Snippet

Sponsor: Eisai Limited | Conditions: Breast Cancer | Status: COMPLETED